PAPER Mateos MJ, Gastelum-Strozzi A, Barrios FA, Bribiesca E, Alcauter S, Marquez-Flores JA
PAPER Henderson MX, Sengupta M, Trojanowski JQ, Lee VM31733655
PAPER Münster Y, Keyvani K, Herring A31734318
PAPER Giangrasso DM, Furlong TM, Keefe KA
Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.Neurobiol Dis. 2019 Nov 15;134:104673. PubMed: 31734455
PAPER Soloveva MV, Jamadar SD, Velakoulis D, Poudel G, Georgiou-Karistianis N31734228
PAPER Zhang J, Park ES, Park HJ, Yan R, Grudniewska M, Zhang X, Oh S, Yang X, Baum J, Mouradian MM
Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice.Neurobiol Aging. 2020 Jan;85:49-57. Epub 2019 Sep 25 PubMed: 31734439
PAPER Hassan R, Rabea AA, Ragae A, Sabry D
The prospective role of mesenchymal stem cells exosomes on circumvallate taste buds in induced Alzheimer's disease of ovariectomized albino rats: (Light and transmission electron microscopic study).Arch Oral Biol. 2019 Oct 31;110:104596. PubMed: 31734542
PAPER Riphagen JM, Ramakers IH, Freeze WM, Pagen LH, Hanseeuw BJ, Verbeek MM, Verhey FR, Jacobs HI31733942
PAPER Hassani OK, Rymar VV, Nguyen KQ, Huo L, Cloutier JF, Miller FD, Sadikot AF
The noradrenergic system is necessary for survival of vulnerable midbrain dopaminergic neurons: implications for development and Parkinson's disease.Neurobiol Aging. 2020 Jan;85:22-37. Epub 2019 Sep 30 PubMed: 31734438
JOB 2019-11-18 Employer Rosalind Franklin University / The Chicago Medical School Principal Investigator Grace Stutzmann Contact firstname.lastname@example.org Description The Center for Neurodegenerative Disease and Therapeutics at the Rosalind Franklin ...
Blade Therapeutics, IncSouth San Francisco, United States
COMMENT This is an extraordinary study that provides a final piece of evidence for the causal involvement of microglia in Alzheimer’s disease. This work follows up a previous report from the same group, where the authors performed transcriptomic analysis of human ...
AstellasCambridge, United States
COMMENT The intriguing and encouraging results of the GV971 trial could be explained by an alternative—or perhaps additional—mechanism: the protective effect against AD might well be the consequence of the drug acting as an antiviral agent against HSV1, which has ...